Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Gains from Investment Securities (2024 - 2025)

Zenas BioPharma (ZBIO) has 1 years of Gains from Investment Securities data on record, last reported at $511100.0 in Q2 2025.

  • For Q2 2025, Gains from Investment Securities changed N/A year-over-year to $511100.0; the TTM value through Jun 2025 reached $511100.0, changed N/A, while the annual FY2023 figure was $100000.0, N/A changed from the prior year.
  • Gains from Investment Securities reached $511100.0 in Q2 2025 per ZBIO's latest filing, up from -$107000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $511100.0 in Q2 2025 and bottomed at -$107000.0 in Q1 2025.